Stocktoria
Q/C TECHNOLOGIES, INC. QCLS
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2008-07-24
Q/C TECHNOLOGIES, INC. statistics & valuation
Market cap$28.1M
P / B1.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -28.2% | -109.0% | -22.4% | -86.6% | -120.5% |
| Return on equity | -53.5% | -238.6% | -32.3% | -103.4% | -126.4% |
| Current ratio | 3.00 | 1.40 | 1.17 | 1.95 | 12.18 |
Source: SEC EDGAR filings · CIK 0001321834 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.